HIGHLIGHTS
- who: Bodan Hu and collaborators from the State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China have published the research work: Vemurafenib Inhibits Enterovirus A71 Genome Replication and Virus Assembly, in the Journal: Pharmaceuticals 2022, 1067 of /2022/
- what: The authors investigated the activity of clinically approved inhibitor used in the treatment of late-stage melanoma. exhibits potent effect in cytopathic effect inhibition and viral load reduction assays with half . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.